Helping You to Uncover Mechanistic Hypotheses to Progress to the Clinic
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors
January 21, 2021: A new article on HER2-targeted tyrosine kinase inhibitors is now online [...]
Predictive approach for clinical response to chemotherapy
December 21: A new article on malignant ascites as a model for drug sensitivity [...]
New website on small molecules for precision oncology: www.ntrctx.com
December 01: Read about NTRC Therapeutics translational science platforms and drug discovery projects at [...]
PREMIUM BENEFITS OF NTRC PRECISION ONCOLOGY: Biochemical Assays, Drug-Target Interactions, Mechanistic Understanding
Selection of compounds with the best structure activity relationship (SAR)
Determination of kinetic and activity-based selectivity
Differentiation of compounds by binding on- and off-rates
Biochemical and cell-based profiling under one roof
Science driven technology platforms
Short turnaround times: gain access to your data in weeks, not months
